STOCK TITAN

Exact Sciences schedules second quarter 2022 earnings call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Exact Sciences Corp. (Nasdaq: EXAS) announced it will release its second quarter 2022 financial results after the U.S. markets close on August 2, 2022. Following the announcement, management will host a webcast and conference call at 5 p.m. ET to discuss the results and business progress. The call is accessible via telephone and will also be available as a recorded archive on their website. Exact Sciences focuses on cancer screening and diagnostic tests, notably with products like Cologuard and Oncotype.

Positive
  • Schedule release of Q2 2022 financial results
  • Webcast and conference call to discuss results enhances transparency
Negative
  • None.

MADISON, Wis., July 8, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2022 financial results after the close of the U.S. financial markets on August 2, 2022. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.

Second quarter 2022 webcast & conference call details

Date:         

Tuesday, August 2, 2022

Time:           

5 p.m. ET

Webcast:

The live webcast can be accessed at www.exactsciences.com

Telephone:

Domestic callers, dial 888-330-2384 
International callers, dial +1 240-789-2701
Access code for both domestic and international callers: 4437608

An archive of the webcast will be available at www.exactsciences.com. A replay of the conference call will be available by calling 800-770-2030 domestically or +1 647-362-9199 internationally. The access code for the replay of the call is 4437608. The webcast, conference call, and replay are open to all interested parties.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-schedules-second-quarter-2022-earnings-call-301582797.html

SOURCE Exact Sciences Corporation

FAQ

When will Exact Sciences release its second quarter 2022 financial results?

Exact Sciences will release its second quarter 2022 financial results after the close of the U.S. markets on August 2, 2022.

What time is the Exact Sciences conference call for Q2 2022 results?

The conference call for Exact Sciences' Q2 2022 results will take place at 5 p.m. ET on August 2, 2022.

How can I access the Exact Sciences Q2 2022 earnings call?

The earnings call can be accessed via telephone or through a live webcast available on Exact Sciences' website.

What is the focus of Exact Sciences Corp.?

Exact Sciences Corp. focuses on cancer screening and diagnostic tests, including products like Cologuard and Oncotype.

Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

EXAS Latest News

EXAS Stock Data

10.55B
182.40M
1.01%
101.74%
7.48%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
MADISON